Tag: Responses

Browse our exclusive articles!

OpenAI Faces Defamation Lawsuit Over ChatGPT’s Behavior

OpenAI's ChatGPT facing serious issues with lack of transparency in user data usage, caught up in Europe's AI law, and dealing with its first defamation lawsuit filed by a Georgia radio host. This serves as a reminder of the need for caution when using AI applications and ensuring they are functioning correctly.

German Researchers Test the Humor of ChatGPT and Its Fun Factor

German aerospace researchers discovered that OpenAI's ChatGPT-3.5 model has limited joke knowledge, with over 90% of generated jokes repeating from a set of 25. While the AI struggled with new sequences and failing jokes, it exhibited knowledge of wordplay and humor elements to some extent.

AI News: ChatGPT Lawyer in Trouble, Nvidia and WPP’s AI Content Engine, Microsoft Raises Bing Chat Limits and More

New York lawyer uses AI tool to write legal brief, adding fake references leading to hot water. NVIDIA and WPP develop content engine, and Microsoft expands Bing Chat's capabilities. AI pioneer calls for regulation.

Clever Memes Inspired by ChatGPT’s Artificial Meme-telligence

Explore 21 hilarious AI memes inspired by ChatGPT, the language model trained with billions of texts. Have a laugh while respecting AI's complexities.

Is ChatGPT More Empathetic than Doctors? How Ideology Can Taint Science, Testing Drugs on Mini-Organs instead of Animals

This article discusses the potential of AI in providing personalized healthcare, as well as sperm count decline and animal testing. ChatGPT is a chatbot built to assist with this, and MIT-Harvard philosopher Alexander Kuthan highlights the need to make sure AI is used ethically. Keep up with the latest developments in AI & healthcare!

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img